197
Participants
Start Date
April 23, 2024
Primary Completion Date
July 1, 2026
Study Completion Date
August 1, 2026
semaglutide 2.4mg
Semaglutide 2.4mg will be self-administered once a week under the surface of the skin and will be started at 0.24mg once a week for 4 weeks; in 4-week intervals, the dose will be increased until a dose of 2.4mg is reached
Placebo
Non-active medication, self-administered
Nicotine Replacement Therapy (NRT, nicotine patch)
Participants who smoke \>10 cigarettes/day will use 21 mg patches for the first 6 weeks, 14 mg patches during weeks 7 and 8, and 7 mg patches during weeks 9 and 10. Participants who smoke 5-10 cigarettes per day will use 14 mg patches for the first 6 weeks and 7 mg patches for weeks 7-10.
Brief Smoking Cessation Counseling
Participants will receive weekly, manual-based individual smoking cessation counseling. Counseling will be provided by master's level clinicians.
RECRUITING
The University of Texas Health Science Center at Houston, Houston
RECRUITING
The University of Texas at Austin, Austin
The University of Texas Health Science Center, Houston
OTHER